Global transcriptome dysregulation in second trimester fetuses with FMR1 expansions

Area of Science:

• Genetics
• Developmental Biology
• Neuroscience

Background:

• Fragile X syndrome is a common genetic cause of intellectual disability.
• The FMR1 gene plays a crucial role in neurodevelopment.
• Early molecular changes in fetal development are not well understood.

Purpose of the Study:

• To investigate if FMR1 expansions cause global gene dysregulation during human fetal development.
• To identify specific cellular functions and pathways affected by FMR1 expansions in the second trimester.
• To explore potential links between fetal gene expression patterns and later clinical manifestations.

Main Methods:

• Analysis of cell-free fetal RNA from amniotic fluid supernatant.
• Utilized expression microarrays to compare RNA levels.
• Compared samples from fetuses with FMR1 premutation/full mutation expansions against control samples.

Main Results:

• Identified differential gene expression in ubiquitination, mitochondrial function, and neuronal/synaptic architecture.
• Observed associations between dysregulated genes and intellectual disability/motor function disorders.
• Detected distinct molecular phenotypes, including mitochondrial dysfunction and disrupted neurological function.
• Noted significant differences in gene expression patterns between male and female fetuses with premutation alleles.

Conclusions:

• FMR1 expansions lead to significant gene dysregulation during human fetal development.
• These early molecular alterations may establish the foundation for FMR1-related disorders.
• The findings support a model where fetal genetic misregulation precedes clinical symptoms.